UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 25

Sortiert nach

Extracellular Deoxyribonuclease Made by Group A Streptococcus Assists Pathogenesis by Enhancing Evasion of the Innate Immune Response

Proceedings of the National Academy of Sciences - PNAS, 2005-02, Vol.102 (5), p.1679-1684

2005

Volltextzugriff (PDF)

Analysis of the Transcriptome of Group A Streptococcus in Mouse Soft Tissue Infection

The American journal of pathology, 2006-09, Vol.169 (3), p.927-942

2006

Volltextzugriff (PDF)

A Mycobacterium ulcerans Toxin, Mycolactone, Causes Apoptosis in Guinea Pig Ulcers and Tissue Culture Cells

Infection and Immunity, 2000-02, Vol.68 (2), p.877-883

2000

Volltextzugriff (PDF)

Is Panton‐Valentine Leukocidin the Major Virulence Determinant in Community‐Associated Methicillin‐Resistant Staphylococcus aureus Disease?

The Journal of infectious diseases, 2006-12, Vol.194 (12), p.1761-1770

2006

Volltextzugriff (PDF)

Internalization of OspA in rsCD14 complex and aggregated forms

Molecular microbiology, 2003-11, Vol.50 (3), p.835-843

2003

Volltextzugriff (PDF)

Mycolactone: A Polyketide Toxin from Mycobacterium ulcerans Required for Virulence

Science (American Association for the Advancement of Science), 1999-02, Vol.283 (5403), p.854-857

1999

Volltextzugriff (PDF)

Acid and base resistance in Escherichia coli and Shigella flexneri: role of rpoS and growth pH

Journal of Bacteriology, 1994-03, Vol.176 (6), p.1729-1737

1994

Volltextzugriff (PDF)

Partial purification and characterization of biological effects of a lipid toxin produced by Mycobacterium ulcerans

Infection and immunity, 1998-02, Vol.66 (2), p.587-593

1998

Volltextzugriff (PDF)

Mycloactone: A polyketide toxin from Mycobacterium ulcerans required for virulence

Science (American Association for the Advancement of Science), 1999-02, Vol.283 (5403), p.854-857

1999

Volltextzugriff (PDF)

Partial Purification and Characterization of Biological Effects of a Lipid Toxin Produced byMycobacterium ulcerans

Infection and Immunity, 1998-02, Vol.66 (2), p.587

1998

Volltextzugriff (PDF)

The D-galactosamine loaded mouse and its enhanced sensitivity to lipopolysaccharide and monophosphoryl lipid A: a role for superoxide

Journal of immunotherapy, 1991-02, Vol.10 (1), p.69

1991

Volltextzugriff (PDF)

Characterization of JNJ-42847922, a Selective Orexin-2 Receptor Antagonist, as a Clinical Candidate for the Treatment of Insomnia

The Journal of pharmacology and experimental therapeutics, 2015-09, Vol.354 (3), p.471

2015

Volltextzugriff (PDF)

Pharmacological characterization of a novel centrally permeable P2X7 receptor antagonist: JNJ‐47965567

British journal of pharmacology, 2013-10, Vol.170 (3), p.624-640

2013

Volltextzugriff (PDF)

Understanding Barriers to Surgical Cancer Care in the Southern Community Cohort Study

Journal of the American College of Surgeons, 2019-10, Vol.229 (4), p.S168-S168

2019

Volltextzugriff (PDF)

Evaluating invasion risk and population dynamics of the brown marmorated stink bug across the contiguous United States

Pest management science, 2022-11, Vol.78 (11), p.4929-4938

2022

Volltextzugriff (PDF)

Evaluation of an immortalized retinal endothelial cell line as an in vitro model for drug transport studies across the blood-retinal barrier

Pharmaceutical research, 2003-09, Vol.20 (9), p.1357-1363

2003

Volltextzugriff (PDF)

Prospective Open-Label Clinical Trial of Trihexyphenidyl in Children With Secondary Dystonia due to Cerebral Palsy

Journal of child neurology, 2007-05, Vol.22 (5), p.530-537

2007

Volltextzugriff (PDF)

Effects of the preservative Purite® on the bioavailability of brimonidine in the aqueous humor of rabbits

Journal of ocular pharmacology and therapeutics, 2004-08, Vol.20 (4), p.285-292

2004

Volltextzugriff (PDF)

A population-based, cross-sectional survey of the zuni pueblo: a collaborative approach to an epidemic of kidney disease

American journal of kidney diseases, 2002-02, Vol.39 (2), p.358-368

2002

Volltextzugriff (PDF)

Formulation effects on ocular absorption of brimonidine in rabbit eyes

Journal of ocular pharmacology and therapeutics, 2002-08, Vol.18 (4), p.325-337

2002

Volltextzugriff (PDF)

Response to Correspondence on “Prospective Open-Label Clinical Trial of Trihexyphenidyl in Children With Secondary Dystonia due to Cerebral Palsy”

Journal of child neurology, 2008-07, Vol.23 (7), p.846-847

2008

Volltextzugriff (PDF)

In vitro and in vivo characterization of JNJ-31020028 (N-(4-{4-[2-(diethylamino)-2-oxo-1-phenylethyl]piperazin-1-yl}-3-fluorophenyl)-2-pyridin-3-ylbenzamide), a selective brain penetrant small molecule antagonist of the neuropeptide Y Y(2) receptor

Psychopharmacology (Berlin, Germany), 2010-02, Vol.208 (2), p.265

2010

Volltextzugriff (PDF)

1 – 25 von 25

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(25)

Sprache

Englisch
(25)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Science & Technology
(17)
Animals
(15)
Life Sciences & Biomedicine
(15)
Mice
(11)
Biological And Medical Sciences
(10)
Female
(8)
Fundamental And Applied Biological Sciences. Psychology
(7)
Humans
(7)
Microbiology
(7)
Bacteriology
(5)
Immunology
(5)
Male
(5)
Medical Sciences
(5)
Pharmacology & Pharmacy
(4)
Rats
(4)
Bacteria
(3)
Bacterial Toxins - Toxicity
(3)
Cell Line
(3)
Disease Models, Animal
(3)
Infectious Diseases
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Extracellular Deoxyribonuclease Made by Group A Streptococcus Assists Pathogenesis by Enhancing Evasion of the Innate Immune Response

Analysis of the Transcriptome of Group A Streptococcus in Mouse Soft Tissue Infection

A Mycobacterium ulcerans Toxin, Mycolactone, Causes Apoptosis in Guinea Pig Ulcers and Tissue Culture Cells

Is Panton‐Valentine Leukocidin the Major Virulence Determinant in Community‐Associated Methicillin‐Resistant Staphylococcus aureus Disease?

Internalization of OspA in rsCD14 complex and aggregated forms

Mycolactone: A Polyketide Toxin from Mycobacterium ulcerans Required for Virulence

Acid and base resistance in Escherichia coli and Shigella flexneri: role of rpoS and growth pH

Partial purification and characterization of biological effects of a lipid toxin produced by Mycobacterium ulcerans

Mycloactone: A polyketide toxin from Mycobacterium ulcerans required for virulence

Partial Purification and Characterization of Biological Effects of a Lipid Toxin Produced byMycobacterium ulcerans

The D-galactosamine loaded mouse and its enhanced sensitivity to lipopolysaccharide and monophosphoryl lipid A: a role for superoxide

Characterization of JNJ-42847922, a Selective Orexin-2 Receptor Antagonist, as a Clinical Candidate for the Treatment of Insomnia

Pharmacological characterization of a novel centrally permeable P2X7 receptor antagonist: JNJ‐47965567

Understanding Barriers to Surgical Cancer Care in the Southern Community Cohort Study

Evaluating invasion risk and population dynamics of the brown marmorated stink bug across the contiguous United States

Evaluation of an immortalized retinal endothelial cell line as an in vitro model for drug transport studies across the blood-retinal barrier

In vitro and in vivo characterization of JNJ-31020028 (N-(4-{4-[2-(diethylamino)-2-oxo-1-phenylethyl]piperazin-1-yl}-3-fluorophenyl)-2-pyridin-3-ylbenzamide), a selective brain penetrant small molecule antagonist of the neuropeptide Y Y2 receptor

Prospective Open-Label Clinical Trial of Trihexyphenidyl in Children With Secondary Dystonia due to Cerebral Palsy

Effects of the preservative Purite® on the bioavailability of brimonidine in the aqueous humor of rabbits

A population-based, cross-sectional survey of the zuni pueblo: a collaborative approach to an epidemic of kidney disease

In vitro and in vivo characterization of JNJ-31020028 (N-(4-{4-[2-(diethylamino)-2-oxo-1-phenylethyl]piperaz in-1-yl}-3-fluorophenyl)-2-pyridin-3-ylbenzamide), a selective brain penetrant small molecule antagonist of the neuropeptide Y Y sub(2) receptor

In vitro and in vivo characterization of JNJ-31020028 N-(4-{4-[2-(diethylamino)-2-oxo-1-phenylethyl]piperazin-1-yl}-3-fluorophenyl)-2-pyridin-3-ylbenzamide, a selective brain penetrant small molecule antagonist of the neuropeptide Y Y2 receptor

Formulation effects on ocular absorption of brimonidine in rabbit eyes

Response to Correspondence on “Prospective Open-Label Clinical Trial of Trihexyphenidyl in Children With Secondary Dystonia due to Cerebral Palsy”

In vitro and in vivo characterization of JNJ-31020028 (N-(4-{4-[2-(diethylamino)-2-oxo-1-phenylethyl]piperazin-1-yl}-3-fluorophenyl)-2-pyridin-3-ylbenzamide), a selective brain penetrant small molecule antagonist of the neuropeptide Y Y(2) receptor

Suchergebnisse filtern